QR-koda

Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus

Background: Type 2 diabetes mellitus (DM) is a risk factor for mycobacterial pulmonary infections (MPI), including tuberculosis (TB) and nontuberculous mycobacterial lung disease (NTM-LD). Dipeptidyl peptidase IV inhibitor (DPP4i), a common DM medication, has an immune-modulation effect that raises...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Cheng-Yi Wang, Kuang-Ming Liao, Ya-Hui Wang, Kuang-Hung Chen, Shulin Chuang, Chia-Jung Liu, Chin-Chung Shu, Hao-Chien Wang
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Elsevier 2023-11-01
Ráidu:Journal of Infection and Public Health
Fáttát:
Diabetes mellitus
Dipeptidyl peptidase IV inhibitors
Nontuberculous mycobacterial lung disease
Mycobacterial pulmonary infection
Tuberculosis
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S187603412300285X
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid